 Organ-specific cardiac antibodies serological markers systemic hypertension autoimmune polyendocrinopathy organ-specific autoantibodies serological markers destruction impairment relevant endocrine tissue cells abnormal hormone levels clinical evidence overt disease organ-specific cardiac antibodies patients autoimmune polyendocrinopathy evidence heart characteristics secretion atrial natriuretic peptide ANP peptide hormones Serum patients polyendocrinopathy autoimmunity gland healthy blood donors antibodies means immunofluorescence human heart Skeletal muscle cross-reacting antibodies Organ-specific cardiac antibodies patients autoimmune polyendocrinopathy autoimmunity gland normal subjects patients autoimmune polyendocrinopathy prevalence systemic hypertension cardiac autoantibodies vs true family history hypertension vs significant differences mean basal ANP concentrations patients antibodies patients controls antibody-positive patients ANP concentrations normal range disturbances systemic hypertension family history disorder Patients autoimmune polyendocrinopathy organ-specific cardiac antibodies novel serological markers autoimmune form systemic hypertension absence overt cardiac disease